Seeking Alpha

Savient Pharmaceuticals (SVNT +12.7%) increases the price per vial for Krystexxa to $5,390 for...

Savient Pharmaceuticals (SVNT +12.7%) increases the price per vial for Krystexxa to $5,390 for orders effectively placed after 5:00pm EST on May 17. The company adds that it will continue to evaluate pricing, noting that continued substantial price increases will, in light of the current market dynamics, be necessary in the effort to obtain sufficient revenue from the drug.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs